Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes

Tsugumichi Saito, Eijiro Yamada, Shuichi Okada, Yoko Shimoda, Yuko Tagaya, Koshi Hashimoto, Tetsurou Satoh, Masatomo Mori, Junichi Okada, Jeffrey E. Pessin, Masanobu Yamada

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The physiology of insulin signaling under normal and disease conditions is well studied in classical insulin target tissues, but not in podocytes. To examine insulin stimulation of podocyte GLUT4 translocation, we established a protocol involving treatment with the PPARα agonist fenofibrate to induce E11 podocyte differentiation within 48 hours rather than 7-10 days, which is required for differentiation under the reported protocol. This allowed us to transiently introduce GLUT4 reporter cDNA and RNAi and thereby to examine the regulatory pathway involved. Here we demonstrate that treatment with 200μM fenofibrate for 36 hours following transfection had a dramatic effect on podocyte morphology, induced several podocyte specific protein expression markers (G protein-coupled receptor 137B, chloride intracellular channel 5, and nephrin) and resulted in insulin-stimulated GLUT4 translocation. In addition, Nucleobindin-2 was found to constitutively associate with Septin 7 (the repressor of GLUT4 translocation), and knockdown of Nucleobindin-2 was found to completely abrogate insulin-stimulated GLUT4 translocation. Together, these data suggest that Nucleobindin-2 may repress Septin7-induced inhibition of insulin-stimulated GLUT4 translocation in podocytes.

Original languageEnglish (US)
Pages (from-to)933-939
Number of pages7
JournalEndocrine Journal
Volume61
Issue number9
DOIs
StatePublished - Sep 1 2014

Fingerprint

Fenofibrate
Podocytes
Facilitative Glucose Transport Proteins
Insulin
Septins
Peroxisome Proliferator-Activated Receptors
Clinical Protocols
G-Protein-Coupled Receptors
RNA Interference
Transfection
nucleobindin
Complementary DNA
Proteins

Keywords

  • Glucose transporter 4 translocation
  • Insulin
  • Insulin resistance
  • Nucleobindin-2
  • Podocyte

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes. / Saito, Tsugumichi; Yamada, Eijiro; Okada, Shuichi; Shimoda, Yoko; Tagaya, Yuko; Hashimoto, Koshi; Satoh, Tetsurou; Mori, Masatomo; Okada, Junichi; Pessin, Jeffrey E.; Yamada, Masanobu.

In: Endocrine Journal, Vol. 61, No. 9, 01.09.2014, p. 933-939.

Research output: Contribution to journalArticle

Saito, T, Yamada, E, Okada, S, Shimoda, Y, Tagaya, Y, Hashimoto, K, Satoh, T, Mori, M, Okada, J, Pessin, JE & Yamada, M 2014, 'Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes', Endocrine Journal, vol. 61, no. 9, pp. 933-939. https://doi.org/10.1507/endocrj.EJ14-0330
Saito, Tsugumichi ; Yamada, Eijiro ; Okada, Shuichi ; Shimoda, Yoko ; Tagaya, Yuko ; Hashimoto, Koshi ; Satoh, Tetsurou ; Mori, Masatomo ; Okada, Junichi ; Pessin, Jeffrey E. ; Yamada, Masanobu. / Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes. In: Endocrine Journal. 2014 ; Vol. 61, No. 9. pp. 933-939.
@article{5b388fdb9ef04863bc45367017a4a9c1,
title = "Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes",
abstract = "The physiology of insulin signaling under normal and disease conditions is well studied in classical insulin target tissues, but not in podocytes. To examine insulin stimulation of podocyte GLUT4 translocation, we established a protocol involving treatment with the PPARα agonist fenofibrate to induce E11 podocyte differentiation within 48 hours rather than 7-10 days, which is required for differentiation under the reported protocol. This allowed us to transiently introduce GLUT4 reporter cDNA and RNAi and thereby to examine the regulatory pathway involved. Here we demonstrate that treatment with 200μM fenofibrate for 36 hours following transfection had a dramatic effect on podocyte morphology, induced several podocyte specific protein expression markers (G protein-coupled receptor 137B, chloride intracellular channel 5, and nephrin) and resulted in insulin-stimulated GLUT4 translocation. In addition, Nucleobindin-2 was found to constitutively associate with Septin 7 (the repressor of GLUT4 translocation), and knockdown of Nucleobindin-2 was found to completely abrogate insulin-stimulated GLUT4 translocation. Together, these data suggest that Nucleobindin-2 may repress Septin7-induced inhibition of insulin-stimulated GLUT4 translocation in podocytes.",
keywords = "Glucose transporter 4 translocation, Insulin, Insulin resistance, Nucleobindin-2, Podocyte",
author = "Tsugumichi Saito and Eijiro Yamada and Shuichi Okada and Yoko Shimoda and Yuko Tagaya and Koshi Hashimoto and Tetsurou Satoh and Masatomo Mori and Junichi Okada and Pessin, {Jeffrey E.} and Masanobu Yamada",
year = "2014",
month = "9",
day = "1",
doi = "10.1507/endocrj.EJ14-0330",
language = "English (US)",
volume = "61",
pages = "933--939",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Nucleobindin-2 is a positive regulator for insulin-stimulated glucose transporter 4 translocation in fenofibrate treated E11 podocytes

AU - Saito, Tsugumichi

AU - Yamada, Eijiro

AU - Okada, Shuichi

AU - Shimoda, Yoko

AU - Tagaya, Yuko

AU - Hashimoto, Koshi

AU - Satoh, Tetsurou

AU - Mori, Masatomo

AU - Okada, Junichi

AU - Pessin, Jeffrey E.

AU - Yamada, Masanobu

PY - 2014/9/1

Y1 - 2014/9/1

N2 - The physiology of insulin signaling under normal and disease conditions is well studied in classical insulin target tissues, but not in podocytes. To examine insulin stimulation of podocyte GLUT4 translocation, we established a protocol involving treatment with the PPARα agonist fenofibrate to induce E11 podocyte differentiation within 48 hours rather than 7-10 days, which is required for differentiation under the reported protocol. This allowed us to transiently introduce GLUT4 reporter cDNA and RNAi and thereby to examine the regulatory pathway involved. Here we demonstrate that treatment with 200μM fenofibrate for 36 hours following transfection had a dramatic effect on podocyte morphology, induced several podocyte specific protein expression markers (G protein-coupled receptor 137B, chloride intracellular channel 5, and nephrin) and resulted in insulin-stimulated GLUT4 translocation. In addition, Nucleobindin-2 was found to constitutively associate with Septin 7 (the repressor of GLUT4 translocation), and knockdown of Nucleobindin-2 was found to completely abrogate insulin-stimulated GLUT4 translocation. Together, these data suggest that Nucleobindin-2 may repress Septin7-induced inhibition of insulin-stimulated GLUT4 translocation in podocytes.

AB - The physiology of insulin signaling under normal and disease conditions is well studied in classical insulin target tissues, but not in podocytes. To examine insulin stimulation of podocyte GLUT4 translocation, we established a protocol involving treatment with the PPARα agonist fenofibrate to induce E11 podocyte differentiation within 48 hours rather than 7-10 days, which is required for differentiation under the reported protocol. This allowed us to transiently introduce GLUT4 reporter cDNA and RNAi and thereby to examine the regulatory pathway involved. Here we demonstrate that treatment with 200μM fenofibrate for 36 hours following transfection had a dramatic effect on podocyte morphology, induced several podocyte specific protein expression markers (G protein-coupled receptor 137B, chloride intracellular channel 5, and nephrin) and resulted in insulin-stimulated GLUT4 translocation. In addition, Nucleobindin-2 was found to constitutively associate with Septin 7 (the repressor of GLUT4 translocation), and knockdown of Nucleobindin-2 was found to completely abrogate insulin-stimulated GLUT4 translocation. Together, these data suggest that Nucleobindin-2 may repress Septin7-induced inhibition of insulin-stimulated GLUT4 translocation in podocytes.

KW - Glucose transporter 4 translocation

KW - Insulin

KW - Insulin resistance

KW - Nucleobindin-2

KW - Podocyte

UR - http://www.scopus.com/inward/record.url?scp=84907520568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907520568&partnerID=8YFLogxK

U2 - 10.1507/endocrj.EJ14-0330

DO - 10.1507/endocrj.EJ14-0330

M3 - Article

VL - 61

SP - 933

EP - 939

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 9

ER -